Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05920_nanopub.RACtWr8PZJqJX7SR9bd3aUtUhID5yKlDfnW-c31eIJMw8#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05920 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05920 label "RTA 744 [drugbank:DB05920]" assertion.
- drugbank:DB05920 seeAlso DB05920 assertion.
- drugbank:DB05920 identifier "drugbank:DB05920" assertion.
- drugbank:DB05920 description "RTA 744 is a novel anthracycline derivative that crosses the blood-brain barrier and shows significant potential for the treatment of primary and metastatic brain cancers. Anthracyclines are one of the most broadly used and effective classes of cancer therapies; however, they are not used to treat brain cancers because current therapies do not cross the blood-brain barrier." assertion.
- drugbank:DB05920 title "RTA 744" assertion.
- drugbank:DB05920 bio2rdf_vocabulary:identifier "DB05920" assertion.
- drugbank:DB05920 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05920 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05920" assertion.
- drugbank:DB05920 bio2rdf_vocabulary:x-identifiers.org DB05920 assertion.
- drugbank:DB05920 drugbank_vocabulary:drugbank-id "DB05920" assertion.
- drugbank:DB05920 drugbank_vocabulary:x-cas cas: assertion.